HLS Therapeutics Inc.

3.47

0.0000

Volume:- -

Turnover:- -

Market Cap:110.23M

PE:-6.08

High:3.47

Open:3.47

Low:3.47

Close:3.47

52wk High:4.02

52wk Low:2.25

Shares:31.79M

Float Shares:19.29M

Volume Ratio:0.02

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5699

EPS(LYR):-0.6173

ROE:-20.02%

ROA:-1.86%

PB:1.79

PE(LYR):-5.62

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Positive Outlook for HLS Therapeutics Inc. Amid Regulatory Developments and Product Approvals

TIPRANKS

·

Nov 20

HLS Therapeutics Inc.: Strategic Resilience and Growth Potential Amidst Market Challenges

TIPRANKS

·

Nov 18

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HLTRF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HLTRF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLTRF\",,,,,undefined,":{"symbol":"HLTRF","market":"US","secType":"STK","nameCN":"HLS Therapeutics Inc.","latestPrice":3.467,"timestamp":1764968400000,"preClose":3.467,"halted":0,"volume":0,"delay":15,"floatShares":19290456,"shares":31793047,"eps":-0.569853,"marketStatus":"Market Closed","change":0,"latestTime":"12-05 16:00:00 EST Delay","open":3.467,"high":3.467,"low":3.467,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.569853,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":3.467,"volumeRatio":0.02272725516530283},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLTRF\",,,,,undefined,":{"symbol":"HLTRF","floatShares":19290456,"roa":"-1.86%","roe":"-20.02%","lyrEps":-0.617315,"volumeRatio":0.02272725516530283,"shares":31793047,"dividePrice":0,"high":3.467,"amplitude":0,"preClose":3.467,"low":3.467,"week52Low":2.25,"pbRate":"1.79","psRate":"1.97","week52High":4.02,"institutionHeld":0,"latestPrice":3.467,"eps":-0.569853,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.569853,"open":3.467,"prevYearClose":2.69,"prevWeekClose":3.467,"prevMonthClose":3.467,"prevQuarterClose":3.8,"fiveDayClose":3.467,"twentyDayClose":4.02,"sixtyDayClose":3.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HLTRF\",params:#limit:5,,,undefined,":[{"date":"2024-05-09","symbol":"HLTRF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715241600000,"name":null,"time":"Pre-Market","dateTimestamp":1715227200000,"actualEps":null},{"market":"US","date":"2023-04-27","symbol":"HLTRF","amount":0.05,"defaultRemindTime":1682602200000,"name":"HLS Therapeutics Inc.","recordDate":"2023-06-15","payableDate":"2023-04-28","currency":"CAD","type":"dividend","dateTimestamp":1682568000000},{"market":"US","date":"2023-01-30","symbol":"HLTRF","amount":0.05,"defaultRemindTime":1675089000000,"name":"HLS Therapeutics Inc.","recordDate":"2023-03-15","payableDate":"2023-01-31","currency":"CAD","type":"dividend","dateTimestamp":1675054800000},{"date":"2022-11-10","symbol":"HLTRF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668070800000,"name":null,"time":"Pre-Market","dateTimestamp":1668056400000,"actualEps":null},{"market":"US","date":"2022-10-28","symbol":"HLTRF","amount":0.05,"defaultRemindTime":1666963800000,"name":"HLS Therapeutics Inc.","recordDate":"2022-12-15","payableDate":"2022-10-31","currency":"CAD","type":"dividend","dateTimestamp":1666929600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HLTRF\",market:\"US\",,,undefined,":[{"executeDate":"2019-01-30","recordDate":"2019-01-31","paymentDate":"2019-03-15","value":0.05,"currency":"CAD"},{"executeDate":"2019-04-29","recordDate":"2019-04-30","paymentDate":"2019-06-14","value":0.05,"currency":"CAD"},{"executeDate":"2019-07-30","recordDate":"2019-07-31","paymentDate":"2019-09-13","value":0.05,"currency":"CAD"},{"executeDate":"2019-10-30","recordDate":"2019-10-31","paymentDate":"2019-12-13","value":0.05,"currency":"CAD"},{"executeDate":"2020-01-30","recordDate":"2020-01-31","paymentDate":"2020-03-13","value":0.05,"currency":"CAD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HLTRF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.4,"hold":0.4,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1755752400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HLTRF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584637132","title":"Positive Outlook for HLS Therapeutics Inc. Amid Regulatory Developments and Product Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2584637132","media":"TIPRANKS","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584637132?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:35","pubTimestamp":1763645740,"startTime":"0","endTime":"0","summary":"David Martin PhD, an analyst from Bloom Burton, maintained the Buy rating on HLS Therapeutics Inc. The associated price target was raised to C$12.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-hls-therapeutics-inc-amid-regulatory-developments-and-product-approvals-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-hls-therapeutics-inc-amid-regulatory-developments-and-product-approvals-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4175","HLTRF","BK4007"],"gpt_icon":0},{"id":"2584368049","title":"HLS Therapeutics Inc.: Strategic Resilience and Growth Potential Amidst Market Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2584368049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584368049?lang=en_us&edition=fundamental","pubTime":"2025-11-18 18:35","pubTimestamp":1763462120,"startTime":"0","endTime":"0","summary":"Analyst David Martin PhD of Bloom Burton maintained a Buy rating on HLS Therapeutics Inc, with a price target of C$9.50. David Martin PhD has given...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hls-therapeutics-inc-strategic-resilience-and-growth-potential-amidst-market-challenges-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hls-therapeutics-inc-strategic-resilience-and-growth-potential-amidst-market-challenges-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HLTRF","BK4007","BK4175"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HLTRF\",params:#limit:6,delay:false,,,undefined,":[]}}